New apalutamide study opens for prostate cancer

February 14, 2018

A new phase 3 study at Providence Cancer Institute will compare the effectiveness of three different treatment regimens in men with biochemically recurrent prostate cancer:

Experimental arm: apalutamide, an investigational, next-generation oral androgen receptor (AR) inhibitor, plus degarelix, a hormonal therapy used to reduce testosterone
Experimental arm: apalutamide and degarelix plus abiraterone acetate and prednisone
Control arm: degarelix alone

“Apalutamide (ARN-509) reduced the risk of metastasis or death by 72% in patients with nonmetastatic castration-resistant prostate cancer,” according to findings from the phase 3 SPARTAN trial reported in OncLive on Feb. 5. The SPARTAN trial, published in the New England Journal of Medicine on Feb. 8, found that “median metastasis-free survival was more than 2 years longer” for men who received apalutamide. Read more in the New York Times.

Brendan Curti, M.D., the principal investigator of the new three-arm study at Providence Cancer Institute, is a medical oncologist and director of genitourinary oncology research at the Earle A. Chiles Research Institute.

See Providence study details here:

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

More prostate cancer studies

This study is one of three clinical trials open to men with prostate cancer at Providence Cancer Institute. See all prostate cancer studies.

To refer patients to any of these studies, call Providence Cancer Institute’s Clinical Research office at 503-215-2614 or visit oregon.providence.org/clinical-trials.

Welcome to your journey for creating a healthier you

New apalutamide study opens for prostate cancer

See Providence study details here:

More prostate cancer studies

Previous Article

Next Article

New apalutamide study opens for prostate cancer

See Providence study details here:

More prostate cancer studies

Previous Article

Next Article

Most Recent Articles

Providence honors the donors who have given the gift of life, health and hope to those in need.

Providence honors the donors who have given the gift of life, health and hope to those in need.

Providence honors the donors who have given the gift of life, health and hope to those in need.

Providence honors the donors who have given the gift of life, health and hope to those in need.

Providence honors the donors who have given the gift of life, health and hope to those in need.

Providence honors the donors who have given the gift of life, health and hope to those in need.

A group of local grade school students took it upon themselves to send well deserved love and gratitude to health care workers in Humboldt County recently.

Our partnership with Microsoft means we are creating access to technology that enables our caregivers to provide better, patient-first care.

Becoming a new parent can be life changing. Ask Gaylee Newbold, RN at Providence Alaska Medical Center’s Mother Baby Unit and she’ll tell you.

Providence Queen of the Valley Medical Center (the Queen) recently became the second hospital in the organization’s Northern California region to begin offering canine companionship to patients.

Get the latest information on healthy living and dietary supplements at our free community presentation by Mark Moyad, M.D.

With the opening of the Epilepsy Monitoring Unit, Providence Mission Hospital is able to treat more patients close to home.

Providence Cancer Institute breast cancer experts are researching new treatments for women with triple-negative breast cancer and HER-2 positive breast cancer.

Providence Little Company of Mary shines the spotlight on their patient's journey in bariatric surgery.

Halloween will be here before we know it! With that in mind, here are some tips to help you enjoy the festivities without the guilt:

For nurse Marlyce Cozart, RN, checking in with residents at Providence Chiniak Bay Elder House on Kodiak Island is like visiting favorite family members.

Winiarski Family Foundation Announces $5.1M Gift

American Heart Association Recognizes Providence Queen of the Valley Medical Center for Treating Stroke Patients Quickly

Providence leaders review the annual report for community investments in Montana. Learn more.